{
    "id": 11227,
    "fullName": "NFE2L2 G31R",
    "impact": "missense",
    "proteinEffect": "gain of function",
    "geneVariantDescriptions": [
        {
            "description": "NFE2L2 G31R lies within a hotspot mutation region in the DLG motif in the NEH2 Keap1 binding domain of the Nfe2l2 protein (PMID: 19321346). G31R may confer a gain of function on the Nfe2L2 protein as demonstrated by the ability to induce tumor formation in animal models (PMID: 27147599).",
            "references": [
                {
                    "id": 3571,
                    "pubMedId": 19321346,
                    "title": "NRF2 and KEAP1 mutations: permanent activation of an adaptive response in cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/19321346"
                },
                {
                    "id": 6273,
                    "pubMedId": 27147599,
                    "title": "Systematic Functional Interrogation of Rare Cancer Variants Identifies Oncogenic Alleles.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/27147599"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 4780,
        "geneSymbol": "NFE2L2",
        "terms": [
            "NFE2L2",
            "HEBP1",
            "IMDDHH",
            "Nrf-2",
            "NRF2"
        ]
    },
    "variant": "G31R",
    "createDate": "09/01/2015",
    "updateDate": "07/10/2016",
    "referenceTranscriptCoordinates": {
        "id": 133848,
        "transcript": "NM_006164",
        "gDna": "chr2:g.177234226C>T",
        "cDna": "c.91G>A",
        "protein": "p.G31R",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 11919,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, overexpression of NFE2L2 (NRF2) G31R resulted in decreased sensitivity to Mekinist (trametinib) in a lung cancer cell line harboring BRAF V600E in culture (PMID: 28145866).",
            "molecularProfile": {
                "id": 28345,
                "profileName": "BRAF V600E NFE2L2 G31R NFE2L2 over exp"
            },
            "therapy": {
                "id": 2,
                "therapyName": "Trametinib",
                "synonyms": null
            },
            "indication": {
                "id": 1324,
                "name": "lung cancer",
                "source": "DOID"
            },
            "responseType": "decreased response",
            "references": [
                {
                    "id": 9896,
                    "pubMedId": 28145866,
                    "title": "KEAP1 loss modulates sensitivity to kinase targeted therapy in lung cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/28145866"
                }
            ],
            "ampCapAscoEvidenceLevel": "NA",
            "ampCapAscoInferredTier": "NA"
        },
        {
            "id": 11918,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, overexpression of NFE2L2 (NRF2) G31R resulted in decreased sensitivity to Zelboraf (vemurafenib) in a lung cancer cell line harboring BRAF V600E in culture (PMID: 28145866).",
            "molecularProfile": {
                "id": 28345,
                "profileName": "BRAF V600E NFE2L2 G31R NFE2L2 over exp"
            },
            "therapy": {
                "id": 342,
                "therapyName": "Vemurafenib",
                "synonyms": null
            },
            "indication": {
                "id": 1324,
                "name": "lung cancer",
                "source": "DOID"
            },
            "responseType": "decreased response",
            "references": [
                {
                    "id": 9896,
                    "pubMedId": 28145866,
                    "title": "KEAP1 loss modulates sensitivity to kinase targeted therapy in lung cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/28145866"
                }
            ],
            "ampCapAscoEvidenceLevel": "NA",
            "ampCapAscoInferredTier": "NA"
        },
        {
            "id": 11920,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, overexpression of NFE2L2 (NRF2) G31R resulted in decreased sensitivity to Mekinist (trametinib) in a lung cancer cell line harboring KRAS G12C in culture (PMID: 28145866).",
            "molecularProfile": {
                "id": 28346,
                "profileName": "KRAS G12C NFE2L2 G31R NFE2L2 over exp"
            },
            "therapy": {
                "id": 2,
                "therapyName": "Trametinib",
                "synonyms": null
            },
            "indication": {
                "id": 1324,
                "name": "lung cancer",
                "source": "DOID"
            },
            "responseType": "decreased response",
            "references": [
                {
                    "id": 9896,
                    "pubMedId": 28145866,
                    "title": "KEAP1 loss modulates sensitivity to kinase targeted therapy in lung cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/28145866"
                }
            ],
            "ampCapAscoEvidenceLevel": "NA",
            "ampCapAscoInferredTier": "NA"
        }
    ],
    "molecularProfiles": [
        {
            "id": 11266,
            "profileName": "NFE2L2 G31R",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 28345,
            "profileName": "BRAF V600E NFE2L2 G31R NFE2L2 over exp",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 28346,
            "profileName": "KRAS G12C NFE2L2 G31R NFE2L2 over exp",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 133846,
            "transcript": "NM_001313903",
            "gDna": "chr2:g.177234226C>T",
            "cDna": "c.91G>A",
            "protein": "p.G31R",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 133847,
            "transcript": "NM_001313902",
            "gDna": "chr2:g.177234226C>T",
            "cDna": "c.91G>A",
            "protein": "p.G31R",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 133848,
            "transcript": "NM_006164",
            "gDna": "chr2:g.177234226C>T",
            "cDna": "c.91G>A",
            "protein": "p.G31R",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}